Concept Life Sciences has a team of immunology experts that helps its clients understand their targets' and compounds' MOA (mechanisms of action) and immunomodulatory effects to progress their drug discovery pipeline.
Concept offers a collaborative and robust experimental design approach and can guide on the most suitable immune cell types, in mono- or co-culture assays. We tailor and develop assays to build data packages that suit our clients’ requirements.
We design exploratory studies to identify where targets are expressed and undertake the fundamental work to help identify a lead compound’s MOA.
We offer a wide range of in vitro and in vivo assays and design experiments with tailored readouts such as FACS, ELISA, multiplex and RNA-seq to suit your requirments. This in vitro approach can mimic the tumour immune cell environment (TME), a specific autoimmune condition and neurodegenerative disease.
Our experienced team offer a tailored program of work and data our clients can trust, giving them greater confidence in lead compound selection and accelerating the best route to clinic.